It was identified from a blood sample taken from one of the first U.S. patients who recovered from COVID-19. About AbCellera Biologics Inc. AbCellera is a privately held technology company with an antibody discovery platform that searches and analyzes natural immune systems to find antibodies that can be used to prevent and treat disease. AbCellera's technology, which combines high-throughput microfluidics, hyper-scale data science, machine learning, bioinformatics, and genomics, identifies new drug candidates and aims to reduce the time it takes to bring treatments to the clinic. AbCellera's partners include leading biotechnology companies, global health organizations, and many of the top 10 biopharmaceutical companies. For more information, visit www.abcellera.com. Inquiries : Jessica Yingling; media@abcellera.com, +1.236.521.6774 (AbCellera Media) Kevin Heyries; bd@abcellera.com, +1.604.559.9005 (AbCellera Business Development)